Reproductive outcomes in adolescent girls with inflammatory diseases of the pelvic organs

In: Russian Pediatric Journal · 2023 · vol. 23(2) , pp. 140–144 · doi:10.46563/1560-9561-2023-26-2-140-144 · W4376135821
article OA: diamond CC0
AI-generated summary by gemini-2.5-flash-lite, 2026-07-08

This review analyzed the reproductive outcomes of inflammatory diseases of the pelvic organs in adolescent girls, identifying recurrent infections, chronic pain, and infertility as leading complications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Introduction. Inflammatory diseases of the pelvic organs (IDPO) are common forms of pathology, which are often accompanied by serious complications. Aim: to determine the leading reproductive outcomes in adolescent girls with IDPO. Materials and methods. The review is based on the analysis of the features of the course of IDPO and the impact of their complications on the reproductive function of adolescent girls. A search was conducted in the PubMed and Cochrane Library databases with a depth of 5 years. Results. It has been established that the highest incidence of IDPO in adolescent girls is at the age of 15–19 years due to the early onset of sexual activity, the lack of effective contraception and the presence of several frequently infected partners. Recurrent infections, chronic pelvic pain, purulent complications (salpingitis, pyosalpinx, tubo-ovarian abscess), ectopic pregnancy, premature birth, endometriosis and infertility are the leading outcomes of IDPO in adolescent girls. It was revealed that the absence of sexual activity does not exclude the occurrence of IDPO and its complications in girls. This is due to the state of immune protection against infectious pathogens in girls, and the qualitative and quantitative composition of the microbiota of the genital tract. Therefore, it is so necessary to manage and conduct a wide screening of adolescents for the presence of sexually transmitted infections to prevent their negative impact on the fertility of young males and females, and effective training of adolescents on all significant issues of reproductive health.
Full text 15,038 characters · extracted from oa-html · click to expand
Репродуктивные исходы у девочек-подростов с воспалительными заболеваниями органов малого таза https://doi.org/10.46563/1560-9561-2023-26-2-140-144 EDN: mynqru Аннотация Введение. Воспалительные заболевания органов малого таза (ВЗОМТ) являются распространёнными формами патологии, которые часто сопровождаются серьёзными осложнениями. Цель: определить ведущие репродуктивные исходы у девочек-подростков после перенесённых воспалительных заболеваний органов малого таза. Материалы и методы. Обзор основан на анализе особенностей течения ВЗОМТ и влияния их осложнений на репродуктивную функцию девочек-подростков. Проведён поиск в базах данных PubMed и Cochrane Library глубиной 5 лет. Результаты. Установлено, что наибольшая частота встречаемости ВЗОМТ у девочек-подростков приходится на возраст 15–19 лет в связи с ранним началом половой жизни, отсутствием эффективной контрацепции и наличием нескольких часто инфицированных партнеров. Ведущими исходами ВЗОМТ у девочек-подростков являются рецидивирующие инфекции, хроническая тазовая боль, гнойные осложнения (сальпингиты, пиосальпинкс, тубоовариальный абсцесс), эктопическая беременность, преждевременные роды, эндометриоз и бесплодие. Выявлено, что отсутствие половой жизни не исключает возникновения ВЗОМТ и его осложнений у девочек. Это обусловлено состоянием иммунной защиты от инфекционных патогенов у девочек, а также качественным и количественным составом микробиоты половых путей. Поэтому так необходимы организация и проведение широкого скрининга подростков на наличие инфекций, передаваемых половым путём, для предупреждения их негативного влияния на фертильность юношей и девушек, а также эффективное обучение подростков по всем значимым вопросам репродуктивного здоровья. Участие авторов: Адамян Л.В., Сибирская Е.В. — концепция и дизайн исследования; Пивазян Л.Г., Лошкарева М.А., Джаруллаева З.У. — сбор и обработка материала; Кириллова Ю.А., Лошкарева М.А. — написание текста; Адамян Л.В., Сибирская Е.В., Шарков С.М. — редактирование. Все соавторы — утверждение окончательного варианта статьи, ответственность за целостность всех частей статьи. Финансирование. Исследование не имело финансовой поддержки. Конфликт интересов. Авторы подтверждают отсутствие конфликта интересов. Поступила 10.02.2023 Принята к печати 21.03.2023 Опубликована 28.04.2023 Об авторах Лейла Владимировна АдамянРоссия Доктор мед. наук, проф., акад. РАН, гл. специалист по гинекологии Минздрава России, зав. каф. репродуктивной медицины и хирургии ФПДО «МГМСУ им. А.И. Евдокимова» e-mail: [email protected] Елена Викторовна Сибирская Россия Доктор мед. наук, проф. каф. репродуктивной медицины и хирургии ФПДО МГМСУ, гл. внештатный специалист — гинеколог детского и юношеского возраста Московской области, зав. гинекологическим отд-нием РДКБ ФГАОУ ВО «РНИМУ им. Н.И. Пирогова» Минздрава России e-mail: [email protected] Сергей Михайлович Шарков Россия Доктор мед. наук, проф. каф. детской хирургии и урологии-андрологии им. проф. Л.П. Александрова, руководитель Московского городского Центра репродуктивного здоровья детей и подростков e-mail: [email protected] Юлия Александровна Кириллова Россия Врач акушер-гинеколог, ОСП РДКБ ФГАОУ ВО «РНИМУ им. Н.И. Пирогова», Москва, Россия e-mail: [email protected] Лаура Горовна Пивазян Россия Ординатор 1 года, ФГБУ «НМИЦ АГП им. В.И. Кулакова» Минздрава России e-mail: [email protected] Мария Александровна Лошкарева Россия Студентка 6 курса, ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский Университет) e-mail: [email protected] Заира Урановна Джаруллаева Россия Студентка 5 курса, ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский Университет) e-mail: [email protected] Список литературы 1. Yusuf H., Trent M. Management of pelvic inflammatory disease in clinical practice. Ther. Clin. Risk Manag. 2023; 19: 183–92. https://doi.org/10.2147/TCRM.S350750 2. Ross J., Guaschino S., Cusini M., Jensen J. 2017 European guideline for the management of pelvic inflammatory disease. Int. J. STD AIDS. 2018; 29(2): 108–14. https://doi.org/10.1177/0956462417744099 3. Sweeney S., Bateson D., Fleming K., Huston W. Factors associated with pelvic inflammatory disease: A case series analysis of family planning clinic data. Womens Health (Lond). 2022; 18: 17455057221112263. https://doi.org/10.1177/17455057221112263 4. Радзинский В.Е., Фукс А.М. Гинекология. М.: ГЭОТАР-Медиа; 2016. 5. Risser W.L., Risser J.M., Risser A.L. Current perspectives in the USA on the diagnosis and treatment of pelvic inflammatory disease in adolescents. Adolesc. Health Med. Ther. 2017; 8(1): 87–94. https://doi.org/10.2147/ahmt.s115535 6. Urbano F., Duarte C.M., Simão C., Águas B.M., Azevedo A.S. Fitz-Hugh-Curtis syndrome – an unexpected diagnosis and the importance of prevention. Pediatr. Oncall. J. 2021; 18: 53–5. https://doi.org/10.7199/ped.oncall.2021.17 7. Cugliari M.K., Pandit T., Pandit R. Small bowel obstruction and appendicitis in patient with Fitz–Hughes–Curtis syndrome. J. Med. Cases. 2022; 13(7): 335–40. https://doi.org/10.14740/jmc3947 8. Chen X., Su J., Xu L., Zhang H. Systematic review and meta-analysis of complications after laparoscopic surgery and open surgery in the treatment of pelvic abscess. Biomed. Res. Int. 2022; 2022: 3650213. https://doi.org/10.1155/2022/3650213 9. Jensen J.S., Cusini M., Gomberg M., Moi H., Wilson J., Unemo M. 2021 European guideline on the management of Mycoplasma genitalium infections. J. Eur. Acad. Dermatol. Venereol. 2022; 36(5): 641–50. https://doi.org/10.1111/jdv.17972 10. Den Heijer C.D., Hoebe C.J., Driessen J.H., Wolffs P., Van Den Broek I.V., Hoenderboom B.M., et al. Erratum to: Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and female infertility: a retrospective cohort study among primary care patients. Clin. Infect. Dis. 2021; 70(11): 2459. https://doi.org/10.1093/cid/ciz897 11. Schmitt T.M., Ohns M.J. Adolescent sexual health challenges in primary care: a case report. J. Pediatr. Health Care. 2021; 35(4): 435–8. https://doi.org/10.1016/j.pedhc.2021.03.008 12. Liu L., Li C., Sun X., Liu J., Zheng H., Yang B., et al. Chlamydia infection, PID, and infertility: further evidence from a case-control study in China. BMC Womens Health. 2022; 22(1): 294. https://doi.org/10.1186/s12905-022-01874-z 13. Wiringa A.E., Ness R.B., Darville T., Beigi R.H., Haggerty C.L. Trichomonas vaginalis, endometritis and sequelae among women with clinically suspected pelvic inflammatory disease. Sex Transm. Infect. 2020; 96(6): 436–8. https://doi.org/10.1136/sextrans-2019-054079 14. Miyoshi Y., Suga S., Sugimi S., Kurata N., Yamashita H., Yasuhi I. Vaginal Ureaplasma urealyticum or Mycoplasma hominis and preterm delivery in women with threatened preterm labor. J. Matern. Fetal. Neonatal. Med. 2022; 35(5): 878–83. https://doi.org/10.1080/14767058.2020.1733517 15. Lewis J., Horner P.J., White P.J. Incidence of pelvic inflammatory disease associated with Mycoplasma genitalium infection: evidence synthesis of cohort study data. Clin. Infect. Dis. 2020; 71(10): 2719–22. https://doi.org/10.1093/cid/ciaa419 16. Solomon M., Tuchman L., Hayes K., Badolato G., Goyal M.K. Pelvic inflammatory disease in a pediatric emergency department. Pediatr. Emerg. Care. 2017; 1. https://doi.org/10.1097/pec.000000000000114 17. Trent M., Haggerty C.L., Jennings J.M., Lee S., Bass D.C., Ness R. Adverse adolescent reproductive health outcomes after pelvic inflammatory disease. Arch. Pediatr. Adolesc. Med. 2011; 165(1): 49–54. https://doi.org/10.1001/archpediatrics.2010.256 18. Han T., Nolan S.M., Regard M. Mycoplasma genitalium as a cause of pelvic inflammatory disease. J. Pediatr. Adolesc. Gynecol. 2020; 33(6): 739–41. https://doi.org/10.1016/j.jpag.2020.06.015 19. Wiesenfeld H.C., Manhart L.E. Mycoplasma genitalium in women: current knowledge and research priorities for this recently emerged pathogen. J. Infect. Dis. 2017; 216(Suppl. 2): 389–95. https://doi.org/10.1093/infdis/jix198 20. Fei Y.F., Lawrence A.E., McCracken K.A. Tubo-ovarian abscess in non-sexually active adolescent girls: a case series and literature review. J. Pediatr. Adolesc. Gynecol. 2021; 34(3): 328–33. https://doi.org/10.1016/j.jpag.2020.12.002 21. Hakim J., Childress K.J., Hernandez A.M., Bercaw-Pratt J.L. Tubo-ovarian abscesses in nonsexually active adolescent females: a large case series. J. Adolesc. Health. 2019; 65(2): 303–5. https://doi.org/10.1016/j.jadohealth.2019.02 22. Getahun S.A., LimaonoJ., Ligaitukana R., Cabenatabua O., Soqo V., Diege R., et al. Ovarian abscess caused by Salmonella enterica serovar Typhi: a case report. J. Med. Case Rep. 2019; 13(1): 303. https://doi.org/10.1186/s13256-019-2229-y 23. Murata T., Endo Y., Furukawa S., Ono A., Kiko Y., Soed S., et al. Successful laparoscopic resection of ovarian abscess caused by Staphylococcus aureus in a 13-year-old girl: a case report and review of literature. BMC Women’s Health. 2021; 21(1): 198. https://doi.org/10.1186/s12905-021-01335-z 24. Tamura S., Jwa S. C., Tarumoto N., Ishihara O. Septic shock caused by Fusobacterium necrophorum following sexual intercourse during recovery from infectious mononucleosis in an adolescent: a case report. J. Pediatr. Adolesc. Gynecol. 2020; 33(5): 566–9. https://doi.org/10.1016/j.jpag.2020.06.018 25. Campbel M., Noor A.A., Castaneda M.A. Case of tubo-ovarian abscess in a 15-year-old female after appendectomy complicated by peritonitis. Cureus. 2021; 13(11): e20052. https://doi.org/10.7759/cureus.20052 26. Kazemi S.N., Arab M., Hosseini M. Pyosalpinx in a virgin female patient misdiagnosed with adnexal torsion: A case report and narrative review. Iran Red Crescent Med. J. 2019; 21(6): e91026. https://doi.org/10.5812/ircmj.91026 27. Pfeifer C.M., Williams L.E., Veltkamp J.G., Lagomarsino E.M. Pediatric pyosalpinx without sexually transmitted infection: A report of 3 cases. Radiol. Case Rep. 2019; 14(4): 501–4. https://doi.org/10.1016/j.radcr.2019.02.001 28. Pradhan S., Kyrillos A., Hayes K., Gromet E., Vash-Margita A., Pennesi C., et al. Pelvic inflammatory disease in non-sexually active pediatric and adolescent patients. J. Pediatr. Adolesc. Gynecol. 2020; 33(2): 242. https://doi.org/10.1016/j.jpag.2020.01.068 29. Mills D., Sharon B., Schneider K. Streptococcus constellatus tubo-ovarian abscess in a non-sexually active adolescent female. Pediatr. Emerg. Care. 2018; 34(6): e100–e101. https://doi.org/10.1097/PEC.0000000000000753 30. Waltmann A., McKinnish T.R., Duncan J.A. Non-viral sexually transmitted infections in pregnancy: current controversies and new challenges. Curr. Opin. Infect. Dis. 2021; 34(1): 40–9. https://doi.org/10.1097/QCO.0000000000000702 31. Huang C.C., Huang C.C., Lin S.Y., Chang C.Y., Lin W.C., Chung C.H., et al. Association of pelvic inflammatory disease (PID) with ectopic pregnancy and preterm labor in Taiwan: A nationwide population-based retrospective cohort study. PLoS One. 2019; 14(8): e0219351. https://doi.org/10.1371/journal.pone.0219351 32. Hoenderboom B.M., van Benthem B.H.B., van Bergen J.E.A.M., Dukers-Muijrers N.H.T.M., Götz H.M., Hoebe C.J.P.A., et al. Relation between Chlamydia trachomatis infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial. Sex Transm. Infect. 2019; 95(4): 300–6. https://doi.org/10.1136/sextrans-2018-053778 33. Anyalechi G.E., Hong J., Kreisel K., Torrone E., Boulet S., Gorwitz R., et al. Self-reported infertility and associated pelvic inflammatory disease among women of reproductive age-national health and nutrition examination survey, United States, 2013-2016. Sex Transm. Dis. 2019; 46(7): 446–51. https://doi.org/10.1097/OLQ.0000000000000996 34. Anyalechi G.E., Wiesenfeld H.C., Kirkcaldy R.D., Kissin D.M., Haggerty C.L., Hammond K.R., et al. Tubal factor infertility, in vitro fertilization, and racial disparities: A retrospective cohort in two US clinics. Sex Transm. Dis. 2021; 48(10): 748–53. https://doi.org/10.1097/OLQ.0000000000001435 35. Tai F.W., Chang C.Y.Y., Chiang J.H., Lin W.C., Wan L. Association of pelvic inflammatory disease with risk of endometriosis: a nationwide cohort study involving 141,460 individuals. J. Clin. Med. 2018; 7: 379. https://doi.org/10.3390/jcm7110379 36. Zondervan K.T., Becker C.M., Koga K., Missmer S.A., Taylor R.N., Viganò P. Endometriosis. Nat. Rev. Dis. Primers. 2018; 4(1): 9. https://doi.org/10.1038/s41572-018-0008-5 37. Hewitt G. Dysmenorrhea and endometriosis: diagnosis and management in adolescents. Clin. Obstet. Gynecol. 2020; 63(3): 536–43. https://doi.org/10.1097/GRF.0000000000000540 38. Khan M. Evaluation of female infertility factors through diagnostic laparoscopy: a cross sectional study. Pak. J. Med. Health Sci. 2021; 15(12): 3871–3. https://doi.org/10.53350/pjmhs2115123871 39. Greydanus D.E., Bacopoulou F. Acute pelvic inflammatory disease. Pediatr. Med. 2019; 2: 36–9. https://doi.org/10.21037/pm.2019.07.05 40. Derouin A.L., Stevenson E.L. Adolescent infertility: a case report. J. Pediatr. Health Care. 2019; 33(2): 206–9. https://doi.org/10.1016/j.pedhc.2018.08.009 41. Agostinis C., Balduit A., Mangogna A., Zito G., Romano F., Ricci G., et al. Immunological basis of the endometriosis: the complement system as a potential therapeutic target. Front. Immunol. 2021; 11: 599117. https://doi.org/10.3389/fimmu.2020.599117 42. Turpin R., Tuddenham S., He X., Klebanoff M.A., Ghanem K.G., Brotman R.M. Bacterial vaginosis and behavioral factors associated with incident pelvic inflammatory disease in the longitudinal study of vaginal flora. J. Infect. Dis. 2021; 224(12 Suppl. 2): 137–44. https://doi.org/10.1093/infdis/jiab103 43. Wang J., Li Z., Ma X., Du L., Jia Z., Cui X., et al. Translocation of vaginal microbiota is involved in impairment and protection of uterine health. Nat. Commun. 2021; 12(1): 4191. https://doi.org/10.1038/s41467-021-24516-8 44. Trent M., Perin J., Rowell J., Shah M., Anders J., Matson P., et al. Using innovation to address adolescent and young adult health disparities in pelvic inflammatory disease: design of the technology enhanced community health precision nursing (TECH-PN) trial. J. Infect. Dis. 2021; 224(12 Suppl. 2): 145–51. https://doi.org/10.1093/infdis/jiab157 Рецензия Для цитирования: Адамян Л.В., Сибирская Е.В., Шарков С.М., Кириллова Ю.А., Пивазян Л.Г., Лошкарева М.А., Джаруллаева З.У. Репродуктивные исходы у девочек-подростов с воспалительными заболеваниями органов малого таза. Российский педиатрический журнал. 2023;23(2):140-144. https://doi.org/10.46563/1560-9561-2023-26-2-140-144. EDN: mynqru For citation: Adamyan L.V., Sibirskaya E.V., Sharkov S.M., Kirillova Yu.A., Pivazyan L.G., Loshkareva M.A., Dzharullaeva Z.U. Reproductive outcomes in adolescent girls with inflammatory diseases of the pelvic organs. Russian Pediatric Journal. 2023;23(2):140-144. https://doi.org/10.46563/1560-9561-2023-26-2-140-144. EDN: mynqru JATS XML

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosischronic_pelvic_paininfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (43)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK